Edition:
India

MYOS RENS Technology Inc (MYOS.OQ)

MYOS.OQ on NASDAQ Stock Exchange Capital Market

1.27USD
1:30am IST
Change (% chg)

$0.04 (+3.25%)
Prev Close
$1.23
Open
$1.21
Day's High
$1.29
Day's Low
$1.21
Volume
3,713
Avg. Vol
20,295
52-wk High
$2.84
52-wk Low
$1.05

Chart for

About

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle... (more)
No analyst recommendations are available for .

Overall

Beta: 0.27
Market Cap(Mil.): $7.89
Shares Outstanding(Mil.): 5.84
Dividend: --
Yield (%): --

Financials

  MYOS.OQ Industry Sector
P/E (TTM): -- 22.59 40.93
EPS (TTM): -0.71 -- --
ROI: -67.54 12.23 62.12
ROE: -68.27 15.60 73.69

BRIEF-Myos Rens Says Qtrly Net Loss Rose 44 Pct To $1.1 MLN

* MYOS RENS TECHNOLOGY REPORTS FOURTH QUARTER AND FISCAL 2017 FINANCIAL RESULTS

28 Mar 2018

BRIEF-Myos Rens Technology Announces Research Agreement With Rutgers University

* MYOS RENS TECHNOLOGY, INC. ANNOUNCES RESEARCH AGREEMENT WITH RUTGERS UNIVERSITY FOCUSED ON DISCOVERY OF COMPOUNDS AND PRODUCTS FOR IMPROVING MUSCLE HEALTH AND PERFORMANCE Source text for Eikon: Further company coverage:

27 Mar 2018

BRIEF-Myos Rens Technology CEO Issues Shareholder Letter

* MYOS RENS TECHNOLOGY CEO ISSUES SHAREHOLDER LETTER Source text for Eikon: Further company coverage:

11 Jan 2018

BRIEF-MYOS RENS Technology reports qtrly loss per share $‍0.13​

* MYOS RENS Technology Inc reports third quarter 2017 financial results

14 Nov 2017

BRIEF-Myos Rens Technology files for mixed shelf of up to $75 mln

* Files for mixed shelf of up to $75 million - sec filing Source text: (http://bit.ly/2z7GifH) Further company coverage:

26 Oct 2017

Competitors

Earnings vs. Estimates